• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

玻璃体内注射羟苯磺酸钙治疗慢性黄斑囊样水肿

Chronic cystoid macular oedema treated with intravitreal dobesilate.

作者信息

Cuevas Pedro, Outeiriño Luis A, Angulo Javier, Giménez-Gallego Guillermo

机构信息

Department of Research, Hospital Ramon y Cajal, Madrid, Spain.

出版信息

BMJ Case Rep. 2012 Jul 9;2012:bcr2012006376. doi: 10.1136/bcr-2012-006376.

DOI:10.1136/bcr-2012-006376
PMID:22778475
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4543391/
Abstract

Dobesilate is an anti-inflammatory and antipermeability agent. Intravitreal administration of this compound is a therapeutically beneficial agent in the treatment of chronic cystoid macular oedema.

摘要

羟苯磺酸是一种抗炎和抗渗透剂。玻璃体腔内注射这种化合物是治疗慢性黄斑囊样水肿的一种有益治疗药物。

相似文献

1
Chronic cystoid macular oedema treated with intravitreal dobesilate.玻璃体内注射羟苯磺酸钙治疗慢性黄斑囊样水肿
BMJ Case Rep. 2012 Jul 9;2012:bcr2012006376. doi: 10.1136/bcr-2012-006376.
2
Treatment of dry age-related macular degeneration with dobesilate.羟苯磺酸钙治疗干性年龄相关性黄斑变性
BMJ Case Rep. 2012 Jun 21;2012:bcr0220125942. doi: 10.1136/bcr.02.2012.5942.
3
Intravitreal dobesilate in the treatment of choroidal neovascularisation associated with age-related macular degeneration: report of two cases.玻璃体内注射羟苯磺酸钙治疗年龄相关性黄斑变性伴脉络膜新生血管：两例报告
BMJ Case Rep. 2012 Sep 3;2012:bcr2012006619. doi: 10.1136/bcr-2012-006619.
4
Treatment of Stargardt disease with dobesilate.羟苯磺酸钙治疗斯塔加特病
BMJ Case Rep. 2012 Oct 12;2012:bcr2012007128. doi: 10.1136/bcr-2012-007128.
5
Durable recovery of the macular architecture and functionality of a diagnosed age-related macular degeneration 1 year after a single intravitreal injection of dobesilate.单次玻璃体内注射羟苯磺酸钙1年后，确诊的年龄相关性黄斑变性患者黄斑结构和功能的持久恢复。
BMJ Case Rep. 2013 Nov 13;2013:bcr2013010203. doi: 10.1136/bcr-2013-010203.
6
Short-term efficacy of intravitreal dobesilate in central serous chorioretinopathy.玻璃体内多贝斯治疗中心性浆液性脉络膜视网膜病变的短期疗效。
Eur J Med Res. 2012 Jul 12;17(1):22. doi: 10.1186/2047-783X-17-22.
7
Cystoid macular edema responds to intravitreal triamcinolone and rebounds after intravitreal bevacizumab.黄斑囊样水肿对玻璃体内注射曲安奈德有反应，而在玻璃体内注射贝伐单抗后会复发。
Ophthalmic Surg Lasers Imaging. 2009 Jul-Aug;40(4):413-5. doi: 10.3928/15428877-20096030-12.
8
[Treatment of cystoid macular edema with bevacizumab in course of Irvine-Gass syndrome].[玻璃体内注射贝伐单抗治疗Irvine-Gass综合征所致黄斑囊样水肿]
Klin Oczna. 2013;115(1):61-4.
9
Cystoid macular oedema associated with Rosai-Dorfman disease: a case report.与罗萨伊-多夫曼病相关的黄斑囊样水肿：一例报告
BMC Ophthalmol. 2017 Aug 14;17(1):141. doi: 10.1186/s12886-017-0538-8.
10
Intravitreal triamcinolone acetonide versus combined intravitreal bevacizumab and dexamethasone in diffuse diabetic macular oedema.玻璃体内曲安奈德与玻璃体内联合贝伐单抗和地塞米松治疗弥漫性糖尿病黄斑水肿。
Clin Exp Ophthalmol. 2011 Sep-Oct;39(7):673-81. doi: 10.1111/j.1442-9071.2011.02504.x. Epub 2011 Mar 24.

引用本文的文献

1
Anti-Angiogenic and Anti-Scarring Dual Action of an Anti-Fibroblast Growth Factor 2 Aptamer in Animal Models of Retinal Disease.抗成纤维细胞生长因子2适体在视网膜疾病动物模型中的抗血管生成和抗瘢痕双重作用
Mol Ther Nucleic Acids. 2019 Sep 6;17:819-828. doi: 10.1016/j.omtn.2019.07.018. Epub 2019 Aug 1.
2
Treatment of Stargardt disease with dobesilate.羟苯磺酸钙治疗斯塔加特病
BMJ Case Rep. 2012 Oct 12;2012:bcr2012007128. doi: 10.1136/bcr-2012-007128.

本文引用的文献

1
Treatment of dry age-related macular degeneration with dobesilate.羟苯磺酸钙治疗干性年龄相关性黄斑变性
BMJ Case Rep. 2012 Jun 21;2012:bcr0220125942. doi: 10.1136/bcr.02.2012.5942.
2
Hepatocyte growth factor stimulated angiogenesis without inflammation: differential actions between hepatocyte growth factor, vascular endothelial growth factor and basic fibroblast growth factor.肝细胞生长因子刺激无炎症血管生成：肝细胞生长因子、血管内皮生长因子和碱性成纤维细胞生长因子的不同作用。
Vascul Pharmacol. 2012 Aug 19;57(1):3-9. doi: 10.1016/j.vph.2012.02.002. Epub 2012 Feb 14.
3
Non-steroidal anti-inflammatory agents for treating cystoid macular oedema following cataract surgery.用于治疗白内障手术后黄斑囊样水肿的非甾体类抗炎药。
Cochrane Database Syst Rev. 2012 Feb 15(2):CD004239. doi: 10.1002/14651858.CD004239.pub3.
4
Inflammasomes in health and disease.炎症小体在健康与疾病中的作用。
Nature. 2012 Jan 18;481(7381):278-86. doi: 10.1038/nature10759.
5
Inhibition of vascular endothelial growth factor (VEGF)-induced endothelial proliferation, arterial relaxation, vascular permeability and angiogenesis by dobesilate.羟苯磺酸钙抑制血管内皮生长因子（VEGF）诱导的内皮细胞增殖、动脉舒张、血管通透性和血管生成。
Eur J Pharmacol. 2011 Sep 30;667(1-3):153-9. doi: 10.1016/j.ejphar.2011.06.015. Epub 2011 Jun 22.
6
Cystic macular oedema on spectral-domain optical coherence tomography in choroideremia patients without cystic changes on fundus examination.脉络膜视网膜变性患者眼底检查未见囊样改变，但频域光相干断层扫描可见囊样黄斑水肿。
Eye (Lond). 2011 Jan;25(1):84-90. doi: 10.1038/eye.2010.157. Epub 2010 Oct 22.
7
Gentisic acid, a compound associated with plant defense and a metabolite of aspirin, heads a new class of in vivo fibroblast growth factor inhibitors.龙胆酸是一种与植物防御有关的化合物，也是阿司匹林的一种代谢物，它是一类新型的体内成纤维细胞生长因子抑制剂。
J Biol Chem. 2010 Apr 9;285(15):11714-29. doi: 10.1074/jbc.M109.064618. Epub 2010 Feb 9.
8
Treatment of cystoid macular edema with the new-generation NSAID nepafenac 0.1%.用新一代非甾体抗炎药0.1%奈帕芬胺治疗黄斑囊样水肿。
Clin Ophthalmol. 2009;3:147-54. doi: 10.2147/opth.s4684. Epub 2009 Jun 2.
9
Effect of calcium dobesilate on occurrence of diabetic macular oedema (CALDIRET study): randomised, double-blind, placebo-controlled, multicentre trial.羟苯磺酸钙对糖尿病性黄斑水肿发生的影响（CALDIRET研究）：随机、双盲、安慰剂对照、多中心试验
Lancet. 2009 Apr 18;373(9672):1364-71. doi: 10.1016/S0140-6736(09)60218-X.
10
A pro-inflammatory signature mediates FGF2-induced angiogenesis.促炎特征介导 FGF2 诱导的血管生成。
J Cell Mol Med. 2009 Aug;13(8B):2083-2108. doi: 10.1111/j.1582-4934.2008.00415.x.